Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid

Current Eye Research

Volumn 16, Issue 2, 1997, Pages 102-110

  Vranka, Janice A ^a,b   Johnson, Elaine ^a   Zhu, Xianghong ^a   Shepardson, Amy ^a   Alexander, J Preston ^a   Bradley, John M B ^a   Wirtz, Mary K ^a,b   Weleber, Richard G ^a,b   Klein, Michael L ^a   Acott, Ted S ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bruch's membrane; Choroidal microvasculature; Human; Macular degeneration; Matrix metalloproteinase inhibitor; Retinal pigment epithelium (RPE)

Indexed keywords

MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BRUCH MEMBRANE; CAPILLARY ENDOTHELIUM; CHOROID; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PERICYTE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CHOROID; CULTURE TECHNIQUES; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROTEASE INHIBITORS; PROTEINS; RETINA; RNA, MESSENGER; TISSUE DISTRIBUTION; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSCRIPTION, GENETIC;

EID: 0031048533     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.16.2.102.5086     Document Type: Article

References (61)

1. Bressler, N. M., Bressler, S. B. and Fine, S. L. (1988) Age-related macular degeneration. Surv. Ophthalmol. 32, 375-413.
2. Deutman, A. F. (1994) Macular dystrophies. In Macular Dystrophies, Vol. 2, (Eds. Schachat, A. P. and Murphy, R. B.). Pp. 1186-1240, Mosby, St. Louis, MO.
3. Hamilton, W. K., Ewing, C. C., Ives, E. J. and Carruthers, J. D. (1989) Sorsby's fundus dystrophy. Ophthalmol. 96, 1755-1762.
4. Capon, M. R. C., Marshall, J., Krafft, J. I., Alexander, R. A., Hiscott, O. S. and Bird, A. C. (1989) Sorsby's fundus dystrophy: a light and electron microscopic study. Ophthalmol. 96, 1769-1777.
5. Hogan, M. J., Alvarado, J. A. and Weddell, J. E. (1971) Histology of the Human Eye: An Atlas and Textbook. Pp. 320 and 393. W. B. Saunders Company, Philadelphia.
6. Zinn, K. M. and Marmor, M. F. (Eds.) (1979) The retinal pigment epithelium. In The Retinal Pigment Epithelium. P. 12. Harvard University Press, Cambridge, MA.
7. Acott, T. S. (1994) Biochemistry of aqueous humor outflow. In Textbook of Ophthalmology, Vol. 7. (Eds. Podos, S. M., Yanoff, M., Kaufman, P. L. and Mittag, T. W.), Pp. 1.47-1.78, Mosby, London.
8. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J. A. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4, 197-250.
9. Denhardt, D. T., Feng, B., Edwards, D. R., Cocuzzi, E. T. and Malyankar, U. M. (1993) Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Therap. 59, 329-341.
10. Matrisian, L. M. (1994) Matrix metalloproteinase gene expression. Ann. N. Y. Acad. Sci. 732, 42-50.
11. Matrisian, L. M. (1992) The matrix-degrading metalloproteinases. Bioessays, 14, 455-463.
12. Murphy, G. and Docherty, A. J. (1992) The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7, 120-125.
13. Murphy, G., Docherty, A. J., Hembry, R. M. and Reynolds, J. J. (1991) Metalloproteinases and tissue damage. Brit. J. Rheum. 1, 25-31.
14. Murphy, G., Willenbrock, F., Crabbe, T., O'Shea, M., Ward, R., Atkinson, S., O'Connell, J. and Docherty, A. (1994) Regulation of matrix metalloproteinase activity. Ann. N. Y. Acad. Sci. 732, 31-41.
15. Nagase, H. (1994) Matrix metalloproteinases. Minireview. Contrib. Nephrol. 107, 85-93.
16. Woessner, J. F. J. (1994) The family of matrix metalloproteinases. Ann. N. Y. Acad. Sci. 732, 11-21.
17. Alexander, C. M. and Werb, Z. (1991) Extracellular matrix degradation. In Extracellular Matrix Degradation, 2nd ed (Ed. Hay, E. D.). Pp. 255-302. Plenum, New York.
18. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. G. (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336.
19. Liotta, L. A., Stetler-Stevenson, W. G. and Steeg, P. S. (1991) Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest. 9, 543-551.
20. Stetler-Stevenson, W. G., Liotta, L. A. and Brown, P. D. (1992) Role of type IV collagenases in human breast cancer. Cancer Treat. Res. 61, 21-41.
21. Apte, S. S., Olsen, B. R. and Murphy, G. (1995) The gene structure of tissue inhibitor of metalloproteinases-3 (TIMP-3) and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270, 14313-14318.
22. Willenbrock, F., Crabbe, T., Slocombe, P. M., Sutton, C. W., Docherty, A. J., Cockett, M. I., O'Shea, M., Brocklehurst, K., Phillips, I. R. and Murphy, G. (1993) The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry, 32, 4330-4337.
23. Apte, S. S., Mattei, M. G. and Olsen, B. R. (1994) Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics, 19, 86-90.
24. Pavloff, N., Staskus, P. W., Kishnani, N. S. and Hawkes, S. P. (1992) A new inhibitor of metalloproteinases from chicken: ChIMP-3, a third member of the TIMP family. J. Biol. Chem. 267, 17321-17326.
25. Silbiger, S. M., Jacobsen, V. L., Cupples, R. L. and Koski, R. A. (1994) Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene, 141, 293-297.
26. Wick, M., Burger, C., Brusselbach, S., Lucibello, F. C. and Muller, R. (1994) A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J. Biol. Chem. 269, 18953-18960.
27. Blenis, J. and Hawkes, S. P. (1983) Transformation-sensitive protein associated with the cell substratum of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 80, 770-774.
28. Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P. and Edwards, D. R. (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269, 9352-9360.
29. Sun, Y., Hegamyer, G., Kim, H., Sithanandam, K., Li, H., Watts, R. and Colburn, N. H. (1995) Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. J. Biol. Chem. 270, 19312-19319.
30. Weber, B. H. F., Vogt, G., Wolz, W., Ives, E. J. and Ewing, C. C. (1994) Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter. Nature Genet. 7, 158-161.
31. Weber, B. H., Vogt, G., Pruett, R. C., Stohr, H. and Felbor, U. (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP-3) in patients with Sorsby's fundus dystrophy. Nature Genet. 8, 352-356.
32. Acott, T. S. and Weleber, R. G. (1995) Vitamin A megatherapy for retinal abnormalities. Nature Med. 1, 3-4.
33. Jacobson, S. G., Cideciyan, A. V., Regunath, G., Rodrigeuz, F. J., Vandenburgh, K., Sheffield, V. C. and Stone, E. M. (1995) Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nature Genet. 11, 27-32.
34. Williamson, R. A., Smith, B. J., Angal, S., Murphy, G. and Freedman, R. B. (1993) Structural analysis of tissue inhibitor of metalloproteinases-1 (TIMP-1) by tryptic peptide mapping. Biochim. Biophys. Acta, 1164, 8-16.
35. Alexander, J. P., Bradley, J. M. B., Gabourel, J. D. and Acott, T. S. (1990) Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 31, 2520-2528.
36. Gabourel, J. D., Bradley, J. M. B. and Acott, T. S. (1990) Antagonism of retinol-induced RNA synthesis: assessment of retinoid toxicity in cultured retinal pigment epithelium. J. Tox.-Cut. Ocul. Toxic. 9, 251-263.
37. Orlidge, A. and D'Amore, P. A. (1987) Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455-1462.
38. Schor, A. M. and Schor, S. L. (1986) The isolation and culture of endothelial cells and pericytes from the bovine retinal microvasculature: a comparison study with large vessel vascular cells. Microvas. Res. 32, 21-38.
39. Chomczynski, P. and Sacchi, N. (1987) Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
40. Parshley, D., Bradley, J., Fisk, A., Hadaegh, A., Samples, J., Van Buskirk, E. and Acott, T. (1996) Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest. Ophthalmol. Vis. Sci. 37, 795-804.
41. Parshley, D. E., Bradley, J. M. B., Samples, J. R., Van Buskirk, E. M. and Acott, T. S. (1995) Early changes in matrix metalloproteinases and inhibitors after in vivo laser treatment to the trabecular meshwork. Curr. Eye Res. 14, 537-544.
42. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular cloning: a laboratory manual. In Molecular Cloning: A Laboratory Manual, 2nd ed. P. 7.37. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
43. Alexander, J. P., Samples, J. R., Van Buskirk, E. M. and Acott, T. S. (1991) Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 32, 172-180.
44. Samples, J. R., Alexander, J. P. and Acott, T. S. (1993) Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest. Ophthalmol. Vis. Sci. 34, 3386-3395.
45. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
46. Ruiz, A., Peterson, B. and Bok, D. (1996) Localization and quantification of TIMP-3 mRNA in the human retina. (Abstract). Invest. Ophthalmol. Vis. Sci. 37 (Suppl.), S1143.
47. MacKenzie, N. E., Gooley, P. R. and Hardaway, L. A. (1992) Solving solution structures of physiologically relevant proteins by NMR spectroscopy. Ann. Rev. Physiol. 54, 749-773.
48. Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M. and Docherty, A. J. (1991) The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry, 30, 8097-8102.
49. Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. I., Eaton, D. and Docherty, A. J. (1992) The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J. 283, 637-641.
50. Jones, S. E., Jomary, C. and Neal, M. J. (1994) Expression of TIMP-3 mRNA is elevated in retinas affected by simplex retinitis pigmentosa. FEBS Lett. 352, 171-174.
51. Brem, H. and Folkman, J. (1975) Inhibition of tumor angiogenesis mediated by cartilage. J. Expt. Med. 141, 427-438.
52. Moses, M. and Langer, R. (1991) A metalloproteinase inhibitor as an inhibitor of neovascularization. J. Cell. Biochem. 47, 230-235.
53. Moses, M. A., Sudhalter, J. and Langer, R. (1990) Identification of an inhibitor of neovascularization from cartilage. Science, 248, 1408-1410.
54. Takigawa, M., Nishida, Y., Suzuki, F., Kishi, J.-I., Yamashita, K. and Hayakawa, T. (1990) Inhibition of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem. Biophys. Res. Commum. 171, 1264-1271.
55. Blankenship, G. W. (1989) Proliferative diabetic retinopathy: principles and techniques of surgical treatment. In Proliferative Diabetic Retinopathy: Principles and Techniques of Surgical Treatment, Vol. 3 (Eds. Ryan, S. J., Glaser, B. M. and Michels, R. G.). Pp. 515-539. C. V. Mosby, St. Louis.
56. Davis, M. D. (1992) Diabetic retinopathy: a clinical overview. Diab. Care, 15, 1844-1874.
57. Davis, M. D. (1989) Proliferative diabetic retinopathy. In Proliferative Diabetic Retinopathy, Vol. 2 (Eds. Ryan, S. J., Schacht, A. P., Murphy, R. B. and Patz, A.). Pp. 367-402. C. V. Mosby, St. Louis.
58. Acott, T. S. (1992) Trabecular extracellular matrix regulation. In Pharmacology of Glaucoma (Eds. Drance, S. M., Van Buskirk, E. M. and Neufeld, A. H.). Pp. 125-157. Williams & Wilkins, Baltimore.
59. Leco, K. J., Hayden, L. J., Sharma, R. R., Rocheleau, H., Greenberg, A. H. and Edwards, D. R. (1992) Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene, 117, 209-217.
60. Della, N. G., Campochiaro, P. A. and Zack, D. J. (1996) Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 37, 1921-1924.
61. Vranka, J. A., Shepardson, A., Johnson, E. C., Zhu, X. H., Alexander, J. P., Bradley, J. M. B., Wirtz, M. K., Weleber, R. G., Klein, M. L. and Acott, T. S. (1996) TIMP-3 expression in the human retina and choroid. (Abstract). Invest. Ophthalmol. Vis. Sci. 37 (Suppl.), S273.